Rhythm Pharmaceuticals Stock Forecast - Simple Moving Average
| RYTM Stock | USD 102.87 5.49 5.07% |
Rhythm Stock outlook is based on your current time horizon. Although Rhythm Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Rhythm Pharmaceuticals' systematic risk associated with finding meaningful patterns of Rhythm Pharmaceuticals fundamentals over time.
As of now, the RSI of Rhythm Pharmaceuticals' share price is approaching 46 indicating that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Rhythm Pharmaceuticals, making its price go up or down. Momentum 46
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.73) | EPS Estimate Current Year (3.08) | EPS Estimate Next Year (2.62) | Wall Street Target Price 141.5714 | EPS Estimate Current Quarter (0.73) |
Using Rhythm Pharmaceuticals hype-based prediction, you can estimate the value of Rhythm Pharmaceuticals from the perspective of Rhythm Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Rhythm Pharmaceuticals using Rhythm Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Rhythm using crowd psychology based on the activity and movement of Rhythm Pharmaceuticals' stock price.
Rhythm Pharmaceuticals Short Interest
An investor who is long Rhythm Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Rhythm Pharmaceuticals and may potentially protect profits, hedge Rhythm Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA 89.1647 | Short Percent 0.119 | Short Ratio 6.48 | Shares Short Prior Month 5.6 M | 50 Day MA 105.7854 |
Rhythm Relative Strength Index
The Simple Moving Average forecasted value of Rhythm Pharmaceuticals on the next trading day is expected to be 102.87 with a mean absolute deviation of 2.90 and the sum of the absolute errors of 171.09.Rhythm Pharmaceuticals Hype to Price Pattern
Investor biases related to Rhythm Pharmaceuticals' public news can be used to forecast risks associated with an investment in Rhythm. The trend in average sentiment can be used to explain how an investor holding Rhythm can time the market purely based on public headlines and social activities around Rhythm Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Rhythm Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Rhythm Pharmaceuticals.
Rhythm Pharmaceuticals Implied Volatility | 0.75 |
Rhythm Pharmaceuticals' implied volatility exposes the market's sentiment of Rhythm Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Rhythm Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Rhythm Pharmaceuticals stock will not fluctuate a lot when Rhythm Pharmaceuticals' options are near their expiration.
The Simple Moving Average forecasted value of Rhythm Pharmaceuticals on the next trading day is expected to be 102.87 with a mean absolute deviation of 2.90 and the sum of the absolute errors of 171.09. Rhythm Pharmaceuticals after-hype prediction price | USD 102.87 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Rhythm Pharmaceuticals to cross-verify your projections. Prediction based on Rule 16 of the current Rhythm contract
Based on the Rule 16, the options market is currently suggesting that Rhythm Pharmaceuticals will have an average daily up or down price movement of about 0.0469% per day over the life of the 2026-04-17 option contract. With Rhythm Pharmaceuticals trading at USD 102.87, that is roughly USD 0.0482 . If you think that the market is fully incorporating Rhythm Pharmaceuticals' daily price movement you should consider acquiring Rhythm Pharmaceuticals options at the current volatility level of 0.75%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Rhythm Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Rhythm Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Rhythm Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Rhythm Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Rhythm Pharmaceuticals' open interest, investors have to compare it to Rhythm Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Rhythm Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Rhythm. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Rhythm Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Rhythm price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Rhythm using various technical indicators. When you analyze Rhythm charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Rhythm Pharmaceuticals Simple Moving Average Price Forecast For the 27th of January
Given 90 days horizon, the Simple Moving Average forecasted value of Rhythm Pharmaceuticals on the next trading day is expected to be 102.87 with a mean absolute deviation of 2.90, mean absolute percentage error of 15.73, and the sum of the absolute errors of 171.09.Please note that although there have been many attempts to predict Rhythm Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Rhythm Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Rhythm Pharmaceuticals Stock Forecast Pattern
| Backtest Rhythm Pharmaceuticals | Rhythm Pharmaceuticals Price Prediction | Buy or Sell Advice |
Rhythm Pharmaceuticals Forecasted Value
In the context of forecasting Rhythm Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Rhythm Pharmaceuticals' downside and upside margins for the forecasting period are 99.57 and 106.17, respectively. We have considered Rhythm Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Rhythm Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Rhythm Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.1903 |
| Bias | Arithmetic mean of the errors | 0.2765 |
| MAD | Mean absolute deviation | 2.8997 |
| MAPE | Mean absolute percentage error | 0.0275 |
| SAE | Sum of the absolute errors | 171.085 |
Predictive Modules for Rhythm Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Rhythm Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Rhythm Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Rhythm Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Rhythm Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Rhythm Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Rhythm Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Rhythm Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Rhythm Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Rhythm Pharmaceuticals' historical news coverage. Rhythm Pharmaceuticals' after-hype downside and upside margins for the prediction period are 99.59 and 106.15, respectively. We have considered Rhythm Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Rhythm Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Rhythm Pharmaceuticals is based on 3 months time horizon.
Rhythm Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Rhythm Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Rhythm Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Rhythm Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.11 | 3.30 | 0.53 | 0.01 | 11 Events / Month | 13 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
102.87 | 102.87 | 0.00 |
|
Rhythm Pharmaceuticals Hype Timeline
Rhythm Pharmaceuticals is at this time traded for 102.87. The entity has historical hype elasticity of 0.53, and average elasticity to hype of competition of -0.01. Rhythm is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is about 68.32%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at -0.11%. %. The volatility of related hype on Rhythm Pharmaceuticals is about 2483.87%, with the expected price after the next announcement by competition of 102.86. About 99.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.75. Rhythm Pharmaceuticals recorded a loss per share of 3.1. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 11 days. Check out Historical Fundamental Analysis of Rhythm Pharmaceuticals to cross-verify your projections.Rhythm Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Rhythm Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Rhythm Pharmaceuticals' future price movements. Getting to know how Rhythm Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Rhythm Pharmaceuticals may potentially react to the hype associated with one of its peers.
Other Forecasting Options for Rhythm Pharmaceuticals
For every potential investor in Rhythm, whether a beginner or expert, Rhythm Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Rhythm Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Rhythm. Basic forecasting techniques help filter out the noise by identifying Rhythm Pharmaceuticals' price trends.View Rhythm Pharmaceuticals Related Equities
| Risk & Return | Correlation |
Rhythm Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Rhythm Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Rhythm Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Rhythm Pharmaceuticals stock market strength indicators, traders can identify Rhythm Pharmaceuticals entry and exit signals to maximize returns.
| Accumulation Distribution | 0.0609 | |||
| Daily Balance Of Power | (0.83) | |||
| Rate Of Daily Change | 0.95 | |||
| Day Median Price | 104.97 | |||
| Day Typical Price | 104.27 | |||
| Market Facilitation Index | 6.59 | |||
| Price Action Indicator | (4.84) | |||
| Period Momentum Indicator | (5.49) | |||
| Relative Strength Index | 46.27 |
Rhythm Pharmaceuticals Risk Indicators
The analysis of Rhythm Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Rhythm Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting rhythm stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.44 | |||
| Standard Deviation | 3.24 | |||
| Variance | 10.52 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Rhythm Pharmaceuticals
The number of cover stories for Rhythm Pharmaceuticals depends on current market conditions and Rhythm Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Rhythm Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Rhythm Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Rhythm Pharmaceuticals Short Properties
Rhythm Pharmaceuticals' future price predictability will typically decrease when Rhythm Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Rhythm Pharmaceuticals often depends not only on the future outlook of the potential Rhythm Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Rhythm Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 61 M | |
| Cash And Short Term Investments | 320.6 M |
Check out Historical Fundamental Analysis of Rhythm Pharmaceuticals to cross-verify your projections. To learn how to invest in Rhythm Stock, please use our How to Invest in Rhythm Pharmaceuticals guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rhythm Pharmaceuticals. If investors know Rhythm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rhythm Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.10) | Revenue Per Share | Quarterly Revenue Growth 0.543 | Return On Assets | Return On Equity |
The market value of Rhythm Pharmaceuticals is measured differently than its book value, which is the value of Rhythm that is recorded on the company's balance sheet. Investors also form their own opinion of Rhythm Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rhythm Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rhythm Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rhythm Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rhythm Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rhythm Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rhythm Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.